Chemoinformaics analysis of (3E)-7-HYDROXY-8-METHOXY-3-[(4-METHOXYPHENYL)METHYLIDENE]CHROMEN-4-ONE
| Molecular Weight | 312.321 | nRot | 3 |
| Heavy Atom Molecular Weight | 296.193 | nRig | 19 |
| Exact Molecular Weight | 312.1 | nRing | 3 |
| Solubility: LogS | -3.93 | nHRing | 1 |
| Solubility: LogP | 2.895 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 2 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 12 |
| nHA | 5 | APOL | 44.7387 |
| nHD | 1 | BPOL | 22.1273 |
| QED | 0.882 |
| Synth | 2.401 |
| Natural Product Likeliness | 0.66 |
| NR-PPAR-gamma | 0.068 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.99 |
| Pgp-sub | 0 |
| HIA | 0.005 |
| CACO-2 | -4.7 |
| MDCK | 0.0000154 |
| BBB | 0.199 |
| PPB | 0.994661 |
| VDSS | 0.496 |
| FU | 0.0198587 |
| CYP1A2-inh | 0.951 |
| CYP1A2-sub | 0.876 |
| CYP2c19-inh | 0.83 |
| CYP2c19-sub | 0.15 |
| CYP2c9-inh | 0.754 |
| CYP2c9-sub | 0.884 |
| CYP2d6-inh | 0.182 |
| CYP2d6-sub | 0.884 |
| CYP3a4-inh | 0.676 |
| CYP3a4-sub | 0.526 |
| CL | 9.034 |
| T12 | 0.425 |
| hERG | 0.062 |
| Ames | 0.962 |
| ROA | 0.662 |
| SkinSen | 0.923 |
| Carcinogencity | 0.877 |
| EI | 0.332 |
| Respiratory | 0.91 |
| NR-Aromatase | 0.805 |
| Antiviral | Yes |
| Prediction | 0.791665 |